DOI: 10.1055/s-00000007

Aktuelle Urologie

Referenz

Joerger M, Cassier PA, Penel N. et al.
Rogaratinib in patients with advanced urothelial carcinomas prescreened for tumor FGFR mRNA expression and effects of mutations in the FGFR signaling pathway.

Journal of Clinical Oncology 2018;
36: 4513

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in: